Nacisa, Aladja A.
HRN: 21-33-45 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/16/2022
AMPICILLIN 1GM (VIAL)
05/16/2022
05/22/2022
IV
2grams
Q6
PROM, MSAF
Waiting Final Action
05/17/2022
CEFUROXIME 500MG (TAB)
05/17/2022
05/23/2022
PO
500mg
BID
UTI
Waiting Final Action